Congenital Langerhans cell histiocytosis is usually limited to cutaneous lesions and has a good prognosis. In rare cases of gut involvement, mortality is high and early and aggressive treatment essential.
We report a case of histiocytosis in a newborn with bowel involvement, and performed a literature review of 13 similar cases worldwide documented between 1973 and 2008.
Skin eruptions are usually the initial symptoms at birth. Bloody stools or protein-losing enteropathy are the first signs of bowel involvement that appear mostly in the first 4 weeks of life. Risk organs (hematopoietic system, liver, spleen) are often affected in the newborns with intestinal Langerhans cell histiocytosis. Prognosis is usually poor, with 78.5% mortality.
Even if histiocytosis in a neonate appears limited to autoinvoluting skin lesions, it is important to exclude all other organ involvement, including the bowel and stomach, as early treatment is vital.
*Department of Pediatrics, Division of Neonatology
†Department of Pediatrics, Division of Oncology
‡Department of Dermatology, Hospital Universitari Son Espases, Palma de Mallorca, Spain
The authors declare no conflict of interest.
Reprints: Susanne Vetter-Laracy, MD, PhD, Department of Pediatrics, Division of Neonatology, Hospital Universitari Son Espases, Carretera Valldemossa 79, Palma de Mallorca 07120, Spain (e-mail: firstname.lastname@example.org).
Received April 19, 2013
Accepted May 8, 2013